Navigation Links
Targeted antibacterial proteins may offer antibiotic alternative
Date:11/20/2011

SOUTH SAN FRANCISCO, CA -- A novel antibacterial protein targeted against E. coli O157:H7 may offer a way to prevent or treat serious food-borne bacterial infections, as demonstrated in a study published in the December issue of Antimicrobial Agents and Chemotherapy. Results in an animal model of E. coli infection showed that the orally administered protein, developed by AvidBiotics, Inc., could prevent or treat E. coli O157:H7-induced diarrhea and intestinal inflammation when administered either on a preventative basis or after the onset of diarrhea. Moreover, animals treated with the protein also carried and shed fewer of the E. coli O157:H7 bacteria in their feces.

"E. coli O157:H7 contamination of foods like ground meats or produce is a well-publicized public health problem, with life-threatening infection outbreaks reported around the world in recent years," said Dean Scholl, Ph.D., lead author of the publication. "Antibiotics are contraindicated for patients infected with enterohemorrhagic E. coli (EHEC) strains like O157:H7, because many of those drugs induce the bacteria to produce and release harmful toxins. Anti-diarrheal medications also do not benefit infected patients, as they cause the bacteria to be retained in the intestines, leading to greater toxin exposure. Thus the successful development of treatments that can prevent infection or limit symptoms and disease duration and the possible further spread of harmful bacteria without increasing toxin release could benefit both individual patients and affected communities."

The study published by Dr. Scholl and his collaborators at AvidBiotics and Brigham and Women's Hospital/Harvard Medical School assessed AvidBiotics' anti-E. coli O157 protein, termed an Avidocin protein, in a rabbit model of infection and reported that:

  • The Avidocin protein remained active within the treated animals' intestinal tract for at leas
    '/>"/>

Contact: Joan Kureczka
Joan@kureczka-martin.com
415-821-2413
Kureczka/Martin Associates
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. On the trail of a targeted therapy for blood cancers
2. Cellular discovery may lead to targeted treatment for rare form of anemia
3. Molecular fingerprints point the way to earlier cancer diagnosis and more targeted treatment
4. Targeted drug therapy prevents exercise-induced arrhythmias
5. Breakthrough in radiotherapy promises targeted cancer treatment
6. Genetic finding could lead to targeted therapy for neuroblastoma
7. New subtype of breast cancer responds to targeted drug
8. Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles
9. UC to test targeted treatment for prostate cancer
10. New mechanisms of tumor resistance to targeted therapy in lung cancer are discovered
11. New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... USC have found that a class of pharmaceuticals can ... , The drugs, known as "TSPO ligands," are currently ... at the effects of TSPO ligand in young adult ... in aged mice when pathology was quite severe," said ... of Gerontology. "TSPO ligand reduced measures of pathology and ...
(Date:5/21/2013)... Chicago College of Medicine will study gender differences in how ... source -- and how changes in fat metabolism play a ... grant from the National Heart, Lung and Blood Institute. , ... energy. These changes may play a major role in the ... women, says E. Douglas Lewandowski, director of the UIC Center ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... For the first time in its history, the French ... granted approval to a private testing company -- the Graduate ... part of its efforts to ensure the highest level of ... obtained this permission. , , GMAC is the international ...
... "grassoline" second generation biofuels made from inedible ... etc. and numerous scientific studies have shown ... to meet our transportation needs. However, before we ... sustainable, carbon-neutral grassoline, numerous barriers must be overcome, ...
... the Department of Energy,s Pacific Northwest National Laboratory has ... Scientists and Engineers. The award honors his research on ... cleaning up buried nuclear or toxic contaminants and storing ... by the White House, the PECASE is the highest ...
Cached Biology News:French Authorities Give Sole Approval to GMAT Exam to Collect Biometric Data to Advance Security 2French Authorities Give Sole Approval to GMAT Exam to Collect Biometric Data to Advance Security 3New technique can fast-track better ionic liquids for biomass pre-treatments 2New technique can fast-track better ionic liquids for biomass pre-treatments 3New technique can fast-track better ionic liquids for biomass pre-treatments 4PNNL scientist garners early career presidential award 2
(Date:5/21/2013)... England , May 22, 2013 ... novel drug-only formulation of glycopyrronium bromide designed using Prosonix, ... pharmaceutical company developing a portfolio of inhaled Respiratory ... clinical study with PSX1002 that will assess its effect ... of doses in patients with moderate to severe chronic ...
(Date:5/21/2013)... Bellingham, WA (PRWEB) May 21, 2013 ... teacher trainings, and funds for lab equipment, 25 organizations ... relevance and importance of optics and photonics in daily ... Grants . , The organizations, located in 10 countries, ... grants to be awarded by SPIE, the international ...
(Date:5/21/2013)... 2013 Savoury Systems International (SSI), a ... Braddy to Southeastern USA Sales Broker. Braddy’s new role ... in the Southeast. , In 2004 Braddy ... supplier to food processors and industrial manufacturers. Braddy ... food industry and has over 25 years of sales ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... 21, 2011 Amsterdam Molecular Therapeutics (Euronext: ... therapy, today announced that the European Medicines Agency,s (EMA) ... maintained its earlier opinion that Glybera (alipogene tiparvovec) is ... contrary to the positive recommendation of CHMP Rapporteurs, the ...
... PARIS, October 21, 2011 , Hepatitis B ... 350  million people worldwide being chronically infected [1] ... [2] - yet there remains a lack of reliable resources ... PATH B - "Patients and Professionals Acting Together for Hepatitis ...
... Today, Congressman Eric Cantor (VA-07) and Tonya Mallory, co-founder, ... Inc.), a CAP accredited leader in health management, ... and economic growth with local business leaders at the ... (Photo: http://photos.prnewswire.com/prnh/20111020/PH91012 ) "We all ...
Cached Biology Technology:Amsterdam Molecular Therapeutics Receives Opinion on Re-examination of Glybera® Marketing Authorisation Application 2Amsterdam Molecular Therapeutics Receives Opinion on Re-examination of Glybera® Marketing Authorisation Application 3"PATH B": A Comprehensive Support Programme in Europe for Patients Diagnosed With Chronic Hepatitis B Launched 2"PATH B": A Comprehensive Support Programme in Europe for Patients Diagnosed With Chronic Hepatitis B Launched 3"PATH B": A Comprehensive Support Programme in Europe for Patients Diagnosed With Chronic Hepatitis B Launched 4Congressman Eric Cantor and Health Diagnostic Laboratory, Inc. Discuss Job Growth at Virginia BioTechnology Research Park 2Congressman Eric Cantor and Health Diagnostic Laboratory, Inc. Discuss Job Growth at Virginia BioTechnology Research Park 3
Contains 0.2 g/L EDTA4Na in phosphate-buffered saline....
MHC Volumes 1 & 2...
Vertical Rack (five box vapor phase rack), includes 2.0" (5.1cm) boxes...
... Casein Kinase 1, active MW: 34.2kDa ... NaCl, 0.02% Brij-35, 1mM dithiothreitiol with ... data, refer to the Certificate of ... Purification: ammonium salt precipitation followed by ...
Biology Products: